D2E7
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for D2E7, covering 2006-08-15 to 2006-08-15. Get the full timeline:
Most recent: Clinical Trial Update: Study of Human Anti-TNF Monoclonal Antibody D2E7 in Subjects With Active Rheumatoid Arthritis [Phase 3]